AXT adds new range of microscopes suited to in situ incubator applications

AXT Pty Ltd is pleased to add the Etaluma range of Lumascopes to their life science portfolio. These compact high-resolution inverted microscopes provide live cell imaging capabilities and have been designed to operate inside standard CO2 incubators.

AXT adds new range of microscopes suited to in situ incubator applications
The Etaluma LS720 Lumascope for live cell imaging within an incubator.

The Lumascope range of microscopes is designed specifically for the examination and analysis of live cell morphology, viability and growth. Etaluma has designed the Lumascope from the ground up. By starting with the application, they are able to avoid redundant features seen in traditional inverted microscopes and instead focus on a custom design for a specific need.

Etaluma’s range of microscopes represents a new concept in digital fluorescence microscopy, which forms the backbone of life science imaging. Capable of produce high-quality multichannel images of both fixed and live samples, they feature zero pixel shift filters, high-resolution camera sensors and modern LED light sources.

With manual or automated options, they accommodate microplates, flasks, dishes, custom labware as well as slides which can be examined in situ inside incubators, biological safety cabinets and other environmentally controlled workstations.

Chris Shumate, CEO of Etaluma said:

We are excited to be working with the AXT team who have an excellent reputation and footprint in the life science microscopy market. We have every confidence that they will grow our market share in Australia and New Zealand."

Etaluma's range of microscopes will make an excellent addition to our product range and support our strategy to bring technologies that enable better live cell imaging to market. Their products are unrivalled on a cost to performance basis. We look forward to showing the capabilities of the Lumascopes to our customers."

Richard Trett, AXT’s Managing Director

Etaluma’s range of live cell imaging microscopes will complement AXT’s existing range of cell biology solutions.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    AXT Pty Ltd. (2020, March 03). AXT adds new range of microscopes suited to in situ incubator applications. News-Medical. Retrieved on December 02, 2024 from https://www.news-medical.net/news/20200303/AXT-adds-new-range-of-microscopes-suited-to-in-situ-incubator-applications.aspx.

  • MLA

    AXT Pty Ltd. "AXT adds new range of microscopes suited to in situ incubator applications". News-Medical. 02 December 2024. <https://www.news-medical.net/news/20200303/AXT-adds-new-range-of-microscopes-suited-to-in-situ-incubator-applications.aspx>.

  • Chicago

    AXT Pty Ltd. "AXT adds new range of microscopes suited to in situ incubator applications". News-Medical. https://www.news-medical.net/news/20200303/AXT-adds-new-range-of-microscopes-suited-to-in-situ-incubator-applications.aspx. (accessed December 02, 2024).

  • Harvard

    AXT Pty Ltd. 2020. AXT adds new range of microscopes suited to in situ incubator applications. News-Medical, viewed 02 December 2024, https://www.news-medical.net/news/20200303/AXT-adds-new-range-of-microscopes-suited-to-in-situ-incubator-applications.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients